Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Experimental Therapeutics

Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model

Nacer Lounis, Tom Gevers, Joke Van Den Berg, Koen Andries
Nacer Lounis
Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nlounis@tibbe.jnj.com
Tom Gevers
Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joke Van Den Berg
Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koen Andries
Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00566-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/AAC.00566-08
PubMed 
18644960

Published By 
American Society for Microbiology Journals
History 
  • Received April 30, 2008
  • Returned for modification June 5, 2008
  • Accepted July 11, 2008
  • Published online September 24, 2008.

Copyright & Usage 
Copyright © 2008 American Society for Microbiology

Article Versions

  • Accepted Manuscript version (July 21, 2008).
  • You are viewing the most recent version of this article.

Author Information

  1. Nacer Lounis*,
  2. Tom Gevers,
  3. Joke Van Den Berg and
  4. Koen Andries
  1. Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium
  • ↵* Corresponding author. Mailing address: Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium. Phone: 32 14 60 65 71. Fax: 32 14 60 54 03. E-mail: nlounis{at}tibbe.jnj.com
View Abstract

Article usage

Article usage: July 2008 to January 2021

Rendering graph...
AbstractFullPdf
Jul 200824035
Aug 200830025
Sep 2008971151
Oct 2008943452
Nov 2008391822
Dec 200817415
Jan 2009161219
Feb 2009142728
Mar 2009171518
Apr 200973021
May 2009278
Jun 200991721
Jul 200941928
Aug 200961216
Sep 200951116
Oct 200981210
Nov 200982017
Dec 2009888
Jan 2010848
Feb 20109126
Mar 20107912
Apr 20103813
May 2010745
Jun 2010387
Jul 2010145
Aug 201011410
Sep 20102117
Oct 20108610
Nov 2010869
Dec 20107712
Jan 2011447
Feb 2011859
Mar 201113149
Apr 2011789
May 201110312
Jun 20118713
Jul 20111339
Aug 201110312
Sep 2011643
Oct 2011846
Nov 20111183
Dec 201121414
Jan 20121418
Feb 201223316
Mar 20121606
Apr 20122219
May 20129613
Jun 2012939
Jul 20121448
Aug 20121847
Sep 20121028
Oct 20121114
Nov 20122006
Dec 2012744
Jan 20131813
Feb 2013813
Mar 201331110
Apr 20132176
May 201316410
Jun 20131743
Jul 20131568
Aug 20131324
Sep 2013736
Oct 20131446
Nov 2013532
Dec 20131155
Jan 2014543
Feb 20141728
Mar 20141797
Apr 201415571
May 20142376
Jun 2014525
Jul 20141976
Aug 2014626
Sep 2014833
Oct 2014557
Nov 2014356
Dec 20141062
Jan 20151164
Feb 2015747
Mar 2015943
Apr 2015621
May 2015315
Jun 2015835
Jul 20151037
Aug 20152185
Sep 20151176
Oct 20151011
Nov 2015523
Dec 20151449
Jan 20161418
Feb 20161524
Mar 2016306314
Apr 20165703
May 201613113
Jun 2016825
Jul 2016754
Aug 2016222
Sep 2016611
Oct 20161754
Nov 201635246
Dec 2016843
Jan 2017824
Feb 20171251
Mar 2017801
Apr 2017501
May 20171720
Jun 2017951
Jul 20171032
Aug 20175131
Sep 20177102
Oct 20173145
Nov 20178163
Dec 20173110
Jan 2018422
Feb 2018831
Mar 201811166
Apr 20186272
May 201812361
Jun 20186252
Jul 20182331
Aug 2018360
Sep 20181213
Oct 201801313
Nov 2018093
Dec 2018092
Jan 20191143
Feb 20191211
Mar 20191907
Apr 201911202
May 20191995
Jun 20191526
Jul 201941535
Aug 201902592
Sep 201902444
Oct 201922679
Nov 201971807
Dec 20194932
Jan 2020166
Feb 2020476
Mar 2020344
Apr 2020281
May 20207108
Jun 20203219
Jul 20203211
Aug 2020225
Sep 20200142
Oct 202033410
Nov 20205282
Dec 20203133
Jan 2021032
PreviousNext
Back to top
Download PDF
Citation Tools
Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model
Nacer Lounis, Tom Gevers, Joke Van Den Berg, Koen Andries
Antimicrobial Agents and Chemotherapy Sep 2008, 52 (10) 3568-3572; DOI: 10.1128/AAC.00566-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model
Nacer Lounis, Tom Gevers, Joke Van Den Berg, Koen Andries
Antimicrobial Agents and Chemotherapy Sep 2008, 52 (10) 3568-3572; DOI: 10.1128/AAC.00566-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antitubercular agents
quinolines
rifampin
Tuberculosis, Pulmonary

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596